2025-11-13T11:07:33-05:00 2024-12-31 251801207 Law Offices of Kathleen D Schneider 1227 South Braddock Avenue Pittsburgh PA 15218 990 2024-01-01 831794049 Translational Research Cancer Cente % Jonathan Bramson TRAN co 1227 South Braddock Avenue Pittsburgh PA 15218 JONATHAN BRAMSON President 2025-11-10 true true KATHLEEN D SCHNEIDER ATTYCPA P00281963 4123711900 X 2024 2025-03-06 01:10:19Z Translational Research Cancer 239968 false X www.trccc.org X 2018 PA Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists. 27 27 0 30 0 0 0 239968 0 0 239968 0 0 0 0 0 121759 121759 118209 92233 213822 3380 92233 210442 Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists. false false 107160 178368 The annual TRCCC meeting provides a unique opportunity for trainees to present and interact in a supportive environment, enhancing their learning experience, skills as medical professionals, and ability to push boudaries in the medical field. The 2024 Meeting was entitled Pushing Immunotherapeutic Boundaries, and consisted of numerous guest speakers from leaders within the immunotherapeutic field and provided atendees with a spatial transcriptomics workshop to learn innovative techniques on current spatial transcriptomics platforms and data analsysis, as well as learn about related emerging technologies. Other topics included, but are not limited to: the impact of the tumor microenvironment on anti-tumor immunity, novel targeting of the immune response in cancer and a discussion of gender in science and academia. 61600 The TRCCC is composed of Cancer Centers, or Academic Institutions with a major focus on cancer research, within an easily accessible distance to the yearly meeting site that advances the dissemination of research and new clinical trials towards the prevention, treatment and cure of cancer, with an emphasis on the study of Immuno-Oncology, immunotherapy and other biological therapies of cancer. Each member institution may choose up to two faculty members to provide their current research in platform presentations, and to have their trainees present short talks and/or posters, at the yearly meeting. Each member institution also can have their Center participate in any clinical trials that are developed at TRC3 centers and other types of inter-institutional scientific collaborations and training opportunities, such as joint NIH training grants, NCI SPORES and P01s. 107160 true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true 0 0 0 false false false false false false false false false false false false X 27 27 false false false false true true false true true false false true true true false false false true true false X Kathleen D Schneider AttyCPA 4123711900 1227 South Braddock Avenue Pittsburgh PA 15218 X Stephen Haley Director 1.00 0.00 X 0 0 0 Kristin Anderson Director 1.00 0.00 X 0 0 0 Sonikpreet Aulakh Director 1.00 0.00 X 0 0 0 Robert Baiocchi Director 1.00 0.00 X 0 0 0 Tullia Bruno Director 1.00 0.00 X 0 0 0 Maria Castro Director 1.00 0.00 X 0 0 0 Grace Chen Director 1.00 0.00 X 0 0 0 Prasenjit Dey Director 1.00 0.00 X 0 0 0 Scott Gerber Director 1.00 0.00 X 0 0 0 Alex Huang Meeting Co-Organizer 1.00 0.00 X 0 0 0 J Melenhorst Meeting Co-Organizer 1.00 0.00 X 0 0 0 Bradley Mills Director 1.00 0.00 X 0 0 0 Scott Olejniczak Director 1.00 0.00 X 0 0 0 Emidio Pistilli Director 1.00 0.00 X 0 0 0 Avery Posey Director 1.00 0.00 X 0 0 0 Anthony Rullo Director 1.00 0.00 X 0 0 0 Melanie Rutkowski Director 1.00 0.00 X 0 0 0 Todd Schell Director 1.00 0.00 X 0 0 0 Kellie Smith Director 1.00 0.00 X 0 0 0 Dario Vignali Director 1.00 0.00 X 0 0 0 Hong Zheng Director 1.00 0.00 X 0 0 0 Daniel J Powell Jr Past President 1.00 0.00 X 0 0 0 Jonathan Bramson President 2.00 0.00 X 0 0 0 Wei-Zen Wei Past President 1.00 0.00 X 0 0 0 Heather Gibson Secretary 2.00 0.00 X 0 0 0 Pawel Kalinski Vice President 2.00 0.00 X 0 0 0 Thomas Mace Treasurer 2.00 0.00 X 0 0 0 0 0 0 0 false false false Annual Convention 611430 178368 178368 Membership Dues 611430 61600 61600 239968 239968 239968 0 0 6060 6060 448 448 111 111 94085 94085 1766 1766 13075 13075 Bank and Merchant Fees 1580 1580 Transaction Fees 4634 4634 121759 107160 14599 0 92233 213822 92233 213822 3380 0 3380 X 92233 210442 92233 210442 92233 213822 118209 0 X true X false false false X 36800 5000 65600 79900 147750 335050 11199 4653 29635 35178 92218 172883 47999 9653 95235 115078 239968 507933 0 0 0 0 0 0 507933 47999 9653 95235 115078 239968 507933 1.00000 1.00000 0.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED PNC Cash Reward Via Credit Card 3380 3380 Members or stockholder classes and rights Part VI line 6 The TRCCC is composed of Cancer Centers, or Academic Institutions with a major focus on cancer research, within an easily accessible distance to the yearly meeting site that supports the purpose statement in Article I, Section 2.2. Member Centers or Institutes shall have several benefits, including voting rights and opportunities for meeting organization and presentation of research (see below) and shall be eligible for membership: 1) after individuals of that cancer center or academic institution attend at least 1 meeting and demonstrate a willingness to contribute to future meetings, and 2) the cancer center or academic institution makes a payment of annual dues. Membership shall be granted upon a majority vote of the board representatives from each represented Cancer Cente Member election for additional members Part VI line 7a Each member center will select two representatives from their faculty to serve as a voting representative on the board for a two-year term, renewable, or if necessary, replaced by that Centers leadership. Form 990 governing body review Part VI line 11 The preparation of the 990 was conducted by an independent accountant. Upon its completion, a copy was furnished to both the organizations Executive Committee for their review and approval. The return was not filed until written approval was received. CEO executive director top management comp Part VI line 15a Per the organizations bylaws, no CEO, executive director or other top management is entitled to any compensation for his or her services to the organization. Consistent with this provision, no such compensation was rendered in 2024. Other officer or key employee compensation Part VI line 15b Per the organizations bylaws, no officer or other key employee is entitled to any compensation for his or her services to the organization. Consistent with this provision, no such compensation was rendered in 2024. Governing documents etc available to public Part VI line 19 Financial records are maintained by the Finance Committee and made available to the public upon request. The Executive Council members are responsible for maintaining the organizations governing documents and will make same available for public review upon request. Such requests can be made by contacting the organization through the contact section on the organizations website - trccc.com.